NO944001L - Farmasöytisk preparat inneholdende diklormetylenbisfofonsyre eller salt derav for oral tilförsel - Google Patents

Farmasöytisk preparat inneholdende diklormetylenbisfofonsyre eller salt derav for oral tilförsel

Info

Publication number
NO944001L
NO944001L NO944001A NO944001A NO944001L NO 944001 L NO944001 L NO 944001L NO 944001 A NO944001 A NO 944001A NO 944001 A NO944001 A NO 944001A NO 944001 L NO944001 L NO 944001L
Authority
NO
Norway
Prior art keywords
salt
oral administration
pharmaceutical preparation
preparation containing
dichloromethylene
Prior art date
Application number
NO944001A
Other languages
English (en)
Other versions
NO944001D0 (no
NO306654B1 (no
Inventor
Juhani Posti
Kirsi Katila
Pertti Rantala
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of NO944001D0 publication Critical patent/NO944001D0/no
Publication of NO944001L publication Critical patent/NO944001L/no
Publication of NO306654B1 publication Critical patent/NO306654B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO944001A 1992-04-24 1994-10-21 Farmasöytisk preparat inneholdende diklormetylenbisfosfonsyre eller salt derav for oral tilförsel NO306654B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201299A SE501389C2 (sv) 1992-04-24 1992-04-24 Farmaceutiskt preparat och förfarande för dess framställning
PCT/FI1993/000166 WO1993021907A1 (en) 1992-04-24 1993-04-21 Pharmaceutical preparation and process for its manufacture

Publications (3)

Publication Number Publication Date
NO944001D0 NO944001D0 (no) 1994-10-21
NO944001L true NO944001L (no) 1994-10-21
NO306654B1 NO306654B1 (no) 1999-12-06

Family

ID=20386054

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944001A NO306654B1 (no) 1992-04-24 1994-10-21 Farmasöytisk preparat inneholdende diklormetylenbisfosfonsyre eller salt derav for oral tilförsel

Country Status (21)

Country Link
US (1) US5525354A (no)
EP (1) EP0637236B1 (no)
JP (1) JP3536106B2 (no)
AT (1) ATE143802T1 (no)
AU (1) AU671830B2 (no)
CA (1) CA2134196C (no)
CZ (1) CZ282871B6 (no)
DE (2) DE69305335T2 (no)
DK (1) DK0637236T3 (no)
EE (1) EE03107B1 (no)
ES (1) ES2094539T3 (no)
FI (1) FI110667B (no)
GR (1) GR3022249T3 (no)
HK (1) HK13097A (no)
HU (1) HU219342B (no)
IL (1) IL105403A (no)
NO (1) NO306654B1 (no)
RU (1) RU2116074C1 (no)
SE (1) SE501389C2 (no)
TW (1) TW273515B (no)
WO (1) WO1993021907A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
DK0625355T5 (da) * 1993-05-15 2003-12-01 Roche Diagnostics Gmbh Tablet med forbedret biotilgængelighed indeholdende dichlormethylendiphosphonsyre som virksomt stof
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
FI98343C (fi) * 1995-03-21 1997-06-10 Orion Yhtymae Oy Peroraalinen formulaatio
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
JPH11137208A (ja) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
EP0998933A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
EP0998932A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
EP1154761B1 (en) * 1999-02-22 2008-02-20 Merrion Research I Limited Solid oral dosage form containing an enhancer
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
PE20011065A1 (es) 2000-02-01 2001-11-21 Procter & Gamble Proceso para fabricar bisfosfonatos geminales
WO2002092069A1 (en) 2001-05-11 2002-11-21 Elan Corporation, Plc Permeation enhancers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
MX2008012678A (es) 2006-04-07 2008-12-17 Merrion Res Iii Ltd Forma de dosis oral solida que contiene un mejorador.
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
RU2517135C2 (ru) 2008-05-07 2014-05-27 Меррион Рисерч Iii Лимитед Композиции пептидов и способы их получения
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
AU2012204213A1 (en) 2011-01-07 2013-06-13 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
DE3767998D1 (de) * 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
EP0313845A1 (en) * 1987-09-29 1989-05-03 Warner-Lambert Company Stabilization of enteric coated dosage form
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique

Also Published As

Publication number Publication date
JP3536106B2 (ja) 2004-06-07
CZ282871B6 (cs) 1997-11-12
DE69305335D1 (de) 1996-11-14
SE9201299D0 (sv) 1992-04-24
DK0637236T3 (da) 1997-03-17
IL105403A (en) 1998-03-10
FI944961A (fi) 1994-10-21
DE637236T1 (de) 1995-07-06
CA2134196C (en) 2004-02-10
ES2094539T3 (es) 1997-01-16
DE69305335T2 (de) 1997-04-30
FI944961A0 (fi) 1994-10-21
RU2116074C1 (ru) 1998-07-27
CA2134196A1 (en) 1993-11-11
NO944001D0 (no) 1994-10-21
WO1993021907A1 (en) 1993-11-11
HU9403067D0 (en) 1994-12-28
EP0637236B1 (en) 1996-10-09
EP0637236A1 (en) 1995-02-08
AU3955093A (en) 1993-11-29
HUT74572A (en) 1997-01-28
HU219342B (en) 2001-03-28
ATE143802T1 (de) 1996-10-15
EE03107B1 (et) 1998-08-17
TW273515B (no) 1996-04-01
AU671830B2 (en) 1996-09-12
HK13097A (en) 1997-02-14
SE501389C2 (sv) 1995-01-30
SE9201299L (sv) 1993-10-25
FI110667B (fi) 2003-03-14
GR3022249T3 (en) 1997-04-30
RU94045950A (ru) 1996-11-10
IL105403A0 (en) 1993-08-18
NO306654B1 (no) 1999-12-06
CZ261494A3 (en) 1995-02-15
US5525354A (en) 1996-06-11
JPH07505898A (ja) 1995-06-29

Similar Documents

Publication Publication Date Title
NO944001L (no) Farmasöytisk preparat inneholdende diklormetylenbisfofonsyre eller salt derav for oral tilförsel
ES2144077T3 (es) Formas de administracion que contienen sales solidas de acido r-tioctico con liberacion y biodisponibilidad mejoradas.
FI950319A0 (fi) Säädellyn vapautumisnopeuden omaava morfiinivalmiste
NO20001417L (no) Farmasøytisk preparat omfattende klodronat som aktiv bestanddel samt silisifiert mikrokrystallinsk cellulose som eksipient
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
ES2062417T3 (es) Composiciones farmaceuticas de cimetidina.
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
ATE321538T1 (de) Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
IS1881B (is) 2,4-dísúlfónýlfenýlbútýlnítrón, sölt þess, lyfjablanda ásamt notkun á þessu efnasambandi við framleiðslu á lyfi
ITMI941408A0 (it) Formulazione a rilascio modificato per la somministrazione di farmaci antiinfiammatori non steroidei